Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for ELMS STEVE
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-06-29
Purchase
2021-07-01
6:29 pm
Elevation Oncology Inc.ELEVAisling Capital IV LP
Aisling Capital Partners IV LLC
Aisling Capital Partners IV LP
ELMS STEVE
SCHIFF ANDREW N
10% Owner
187,500$16$3,000,0002,834,910
(Direct)
View
2021-03-16
Purchase
2021-03-18
4:35 pm
Marker Therapeutics Inc.MRKRELMS STEVE
Director
1,142,857$1.75$2,000,0003,159,879
(Indirect
Direct)
View
2019-07-15
Purchase
2019-07-15
4:15 pm
SUNESIS PHARMACEUTICALS INCSNSSAisling Capital IV LP
Aisling Capital Partners IV LLC
Aisling Capital Partners IV LP
SCHIFF ANDREW N
ELMS STEVE
10% Owner
2,500,000$0.6$1,500,00010,100,000
(Indirect)
View
2018-07-10
Sale
2018-07-12
4:45 pm
Loxo Oncology Inc.LOXOAISLING CAPITAL III LP
Aisling Capital Partners III LP
Aisling Capital Partners III LLC
ELMS STEVE
SCHIFF ANDREW N
Purcell Dennis J
10% Owner
1,400,000$179.43$251,202,0002,038,920
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-06-17
Option Award
2022-06-22
6:43 pm
N/A
2032-06-16
Elevation Oncology Inc.ELEVAisling Capital IV LP
Aisling Capital Partners IV LLC
Aisling Capital Partners IV LP
ELMS STEVE
SCHIFF ANDREW N
10% Owner
15,619$015,619
(Indirect)
View
2022-05-24
Option Award
2022-05-26
4:09 pm
N/A
2032-05-23
Marker Therapeutics Inc.MRKRELMS STEVE
Director
80,000$080,000
(Direct)
View
2022-03-07
Option Award
2022-03-09
5:59 pm
N/A
2032-03-07
ADMA BIOLOGICS IncADMAELMS STEVE
Director
79,758$03,695,429
(Direct)
View
2021-06-29
Conversion
2021-07-01
6:29 pm
N/A
N/A
Elevation Oncology Inc.ELEVAisling Capital IV LP
Aisling Capital Partners IV LLC
Aisling Capital Partners IV LP
ELMS STEVE
SCHIFF ANDREW N
10% Owner
12,288,426$02,834,910
(Direct)
View
2021-06-24
Option Award
2021-06-28
6:18 pm
N/A
2031-06-23
Elevation Oncology Inc.ELEVAisling Capital IV LP
Aisling Capital Partners IV LLC
Aisling Capital Partners IV LP
ELMS STEVE
SCHIFF ANDREW N
10% Owner
31,238$031,238
(Indirect)
View
2021-06-24
Ownership
2021-06-24
6:32 pm
N/A
N/A
Elevation Oncology Inc.ELEVAisling Capital IV LP
ELMS STEVE
Aisling Capital Partners IV LLC
Aisling Capital Partners IV LP
SCHIFF ANDREW N
10% Owner
0$02,647,410
(Direct)
View
2021-06-10
Option Award
2021-06-14
8:38 pm
N/A
2031-06-09
Zosano Pharma CorpZSANELMS STEVE
Director
45,000$02,770,726
(Direct)
View
2021-06-08
Option Award
2021-06-10
6:55 pm
N/A
N/A
Marker Therapeutics Inc.MRKRELMS STEVE
Director
12,658$03,172,537
(Direct)
View
2021-02-25
Option Award
2021-03-01
9:02 pm
N/A
2031-02-25
ADMA BIOLOGICS IncADMAELMS STEVE
Director
55,000$055,000
(Direct)
View
2020-12-31
Ownership
2021-02-12
5:12 pm
N/A
N/A
Marker Therapeutics Inc.MRKRELMS STEVE
Director
0$02,017,022
(Indirect)
View
2020-12-31
Ownership
2021-02-12
5:12 pm
N/A
N/A
Marker Therapeutics Inc.MRKRELMS STEVE
Director
17,022$02,017,022
(Direct)
View
2020-06-25
Option Award
2020-06-29
9:47 pm
N/A
N/A
Zosano Pharma CorpZSANELMS STEVE
Director
7,500$02,725,766
(Direct)
View
2020-06-03
Option Award
2020-06-05
5:10 pm
N/A
2030-06-02
Zosano Pharma CorpZSANELMS STEVE
Director
15,000$015,000
(Direct)
View
2020-02-28(A)
Option Award
2020-05-01
5:12 pm
N/A
N/A
ADMA BIOLOGICS IncADMAELMS STEVE
Director
7,500$07,500
(Direct)
View
2020-02-28
Option Award
2020-03-03
7:11 pm
N/A
2030-02-28
ADMA BIOLOGICS IncADMAELMS STEVE
Director
22,500$022,500
(Direct)
View
2019-12-02
Option Award
2019-12-06
10:23 am
N/A
N/A
Zosano Pharma CorpZSANAisling Capital IV LP
Aisling Capital Partners IV LP
Aisling Capital Partners IV LLC
ELMS STEVE
SCHIFF ANDREW N
10% Owner
689,655$1.452,718,226
(Direct)
View
2019-08-06
Option Award
2019-08-08
5:07 pm
N/A
2029-08-06
Marker Therapeutics Inc.MRKRELMS STEVE
Director
12,500$012,500
(Direct)
View
2019-08-06
Ownership
2019-08-08
5:06 pm
N/A
N/A
Marker Therapeutics Inc.MRKRELMS STEVE
Director
0$03,500,000
(Indirect)
View
2019-01-02
Option Award
2019-07-18
4:07 pm
N/A
2029-01-02
Zosano Pharma CorpZSANELMS STEVE
Director
10% Owner
1,500$01,500
(Direct)
View
2019-04-11
Option Award
2019-04-12
4:15 pm
N/A
N/A
Zosano Pharma CorpZSANAisling Capital IV LP
Aisling Capital Partners IV LP
Aisling Capital Partners IV LLC
ELMS STEVE
SCHIFF ANDREW N
10% Owner
428,571$3.52,028,571
(Direct)
View
2019-03-13
Option Award
2019-03-15
5:01 pm
N/A
2029-03-13
ADMA BIOLOGICS IncADMAELMS STEVE
Director
30,000$030,000
(Direct)
View
2019-02-15
Disposition
2019-02-15
09:09 am
N/A
2024-07-30
Loxo Oncology Inc.LOXOELMS STEVE
Director
10% Owner
50,999$2352,038,920
(Direct)
View
2019-02-15
Equity Swap
2019-02-15
09:09 am
N/A
N/A
Loxo Oncology Inc.LOXOELMS STEVE
Director
10% Owner
2,038,920$2352,038,920
(Indirect)
View
2019-01-23
Ownership
2019-01-24
5:23 pm
N/A
N/A
SUNESIS PHARMACEUTICALS INCSNSSAisling Capital IV LP
Aisling Capital Partners IV LLC
Aisling Capital Partners IV LP
SCHIFF ANDREW N
ELMS STEVE
10% Owner
0$07,600,000
(Indirect)
View
2018-06-22
Option Award
2018-06-25
5:01 pm
N/A
2028-06-22
ADMA BIOLOGICS IncADMAELMS STEVE
Director
17,500$017,500
(Direct)
View
2018-06-13
Option Award
2018-06-14
5:01 pm
N/A
2028-06-12
Loxo Oncology Inc.LOXOELMS STEVE
Director
10% Owner
8,750$08,750
(Direct)
View
2018-05-17
Option Award
2018-05-21
8:16 pm
N/A
2028-05-17
Zosano Pharma CorpZSANELMS STEVE
Director
10% Owner
25,000$025,000
(Direct)
View
2018-03-29(A)
Ownership
2018-04-12
4:05 pm
N/A
N/A
Zosano Pharma CorpZSANAisling Capital IV LP
Aisling Capital Partners IV LP
Aisling Capital Partners IV LLC
ELMS STEVE
SCHIFF ANDREW N
10% Owner
0$01,600,000
(Direct)
View
2018-03-29
Ownership
2018-04-09
4:53 pm
N/A
N/A
Zosano Pharma CorpZSANAisling Capital IV LP
ELMS STEVE
SCHIFF ANDREW N
10% Owner
0$01,600,000
(Direct)
View
(A) Indicate amendment filing.